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Abstract  
Objective: To determine the predictive markers for the occurrence of upper limb spasticity in 
the first 12 months after stroke.  
Data Sources: A systematic review was undertaken of the databases MEDLINE, EMBASE, 
CINAHL and PEDRO to 31st December 2017.  
Study Selection: Non-experimental or experimental studies that included a control group 
with spasticity who did not receive an experimental intervention which investigated at least 
one variable (explanatory variable) measured at baseline against the development (or not) of 
spasticity at a future time point within 12 months post-stroke were selected independently by 
two reviewers. Eleven papers met the selection criteria. 
Study Appraisal: Data were extracted into tabular format using predefined data fields by 
two reviewers. Study quality was evaluated using the modified Downs and Black tool. Data 
were analysed using a meta-analysis or narrative review.  
Results: Ten studies, including 858 participants were analysed. The predictive markers of 
upper limb spasticity at one month post-stroke were: motor 11.25 (odds ratio, OR); [95% 
CI:2.48, 51.04] and sensory impairments 4.91 (OR); [1.24,19.46]; haemorrhagic stroke 3.70 
(OR); [1.05, 12.98] and age 0.01 (OR) [0.00, 69.89]. Only motor impairment was found as a 
significant predictor at six months post-stroke 30.68 (OR); [1.60, 587.06].  
Limitations: Low number of studies exploring biomechanical and neurophysiological in 
addition to clinical predictors of spasticity were included.  
Conclusion and implications of key findings: Using the results, the identified predictive 












rehabilitation interventions by physiotherapists for stroke survivors with upper limb 
spasticity.  
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Introduction 
Stroke is the third leading cause of adult disability worldwide [1]. Upper limb deficits are 
frequent, despite the benefits of rehabilitation, with 33 to 66% of people reporting a lack of 
upper limb function at six months after stroke [2,3]. Consequentially everyday activity such as 
picking up a glass of water and fastening zips are difficult if not impossible for many stroke 
survivors. Key factors associated with poor upper limb recovery are: lesion location, initial 
severity of motor impairment or function, and changes in muscle tone such as the development 
of spasticity over time [4,5].  
Spasticity is a complex sensori-motor disorder which has been defined as “impaired sensori-
motor control from an upper motor neuron lesion, presenting as intermittent or sustained 
involuntary activation of muscles” [6]. Alleviation of spasticity is a rehabilitation focus when 
it limits activity due to contractures and/or pain [7,8]. The cost of healthcare for stroke 
survivors with spasticity has been estimated as being four-times higher than when spasticity is 
not a secondary complication [9]. Unfortunately, for many people, upper limb spasticity is 
common [10,11]. At Day Three post-stroke, spasticity is present in approximately 25% of 
people who have upper limb paresis and frequency can increase up to 46% at 12 months [12].  
A limited understanding of the predictors of developing upper limb spasticity can limit the 
application of rehabilitation interventions. Enhanced understanding of the predictive markers 
of upper limb spasticity could enable physiotherapists to identify people at higher risk leading 












strategies. Prior to commencing this study, a scoping literature search conducted and did not 
find any high-quality systematic reviews of predictive markers of upper limb spasticity after 
stroke. Two narrative reviews have explored the predictive markers of the early development 
of upper limb spasticity after stroke [13,14] although neither used a comprehensive search 
strategy, assessed the potential risk of bias of included studies, or provided information about 
the characteristics of included studies. The aim of this systematic review is therefore to 
determine the predictive markers of upper limb spasticity after stroke.  
The systematic review was registered on PROSPERO (ID: CRD42016027642). 
Study criteria 
Types of study design: (a) non-experimental such as cohort and case control studies, or 
experimental studies that included a control group with spasticity who did not receive an 
experimental intervention, (b) which investigated at least one variable (explanatory variable) 
measured at baseline against the development (or not) of spasticity at a future time point within 
12 months post-stroke [5].  
Types of participants: (a) had a confirmed clinical diagnosis of a haemorrhagic or ischaemic 
stroke and (b) upper limb spasticity as measured by the Modified Ashworth Scale (MAS) 
scored greater than or equal to one point [15]. Participants were excluded if they had an 
additional neurological condition such as Parkinson’s disease, multiple sclerosis or upper limb 
peripheral neuropathy.  
Outcome measures of potential predictors: (a) age (< or ≥65 years); (b) gender (female, male); 
(c) behavioural habits such as smoking (>5 cigarettes/day) [23]; (d) handedness (right, left); 
(e) upper limb motor impairment defined as score >2 on item 5 on the National Institutes of 
Health Stroke Scale (NIHSS) [10, 16]; (f) upper limb somatosensory impairment as defined as 












stroke (cortical, subcortical, mixed); (i) type of stroke (ischemic, haemorrhagic); (j) muscle 
activity measured by electromyography; and (k) biomarkers measured by brain imaging or non-
invasive brain stimulation.  
Search Strategy 
A search of the databases MEDLINE, EMBASE (Excerpta Medica Database), CINAHL 
(Cumulated Index of Nursing and Allied Health Literature) and PEDRO (Physiotherapy 
Evidence Database) was conducted from database inception to 31st December 2017. A 
summary of the search strategy is presented in the Appendix (Table A). A hand search of the 
reference lists of each included article and the identified literature reviews were also screened 
for relevant publications.  
The titles and/or abstract from the search results were independently screened against the pre-
determined inclusion criteria by two reviewers. The full-text version of all papers which were 
potentially eligible were obtained and independently reviewed by the same two reviewers. 
Papers which satisfied the eligibility criteria at this stage were included in the review. 
Disagreement in eligibility judgment between the reviewers was resolved through consultation 
of the full-text article and discussion.  
Risk of potential bias appraisal and Data Extraction 
Two review authors independently critically appraised the included studies for risk of potential 
bias using the modified Downs and Black assessment [17,18]. This modified version of the 
tool has been previously reported [19]. The assessment contains 27 ‘yes’-or-'no’ questions 
across five sections. To make it specific to the research question, items related to randomisation 
and intervention were removed. This process left 17 items exploring: (1) study quality (seven 
items) – the overall quality of the study; (2) external validity (three items) – the ability to 












measure(s); and (4) confounding and selection bias (two items) – determines bias from 
sampling or group assignment. Disagreements were resolved through consultation of the full-
text publication and discussion. Papers achieving at least 65% of the maximum possible score 
was classified as having ‘substantial’ quality [19].  
Data extracted were: number of participants, gender, side of stroke, type and location of stroke, 
time since stroke and any predictor characteristics that were identified, for example clinical 
assessment of spasticity, upper limb strength. Data extraction was carried independently by 
two reviewers into a table proforma developed by authors. Disagreements were resolved by 
including a third reviewer. 
Data Synthesis 
Demographic characteristics of mean age, frequency of males/females, type of stroke and 
characteristics of pre- and post-stroke presentation were calculated. Between-study 
heterogeneity was evaluated through visual analysis of the completed dataset. Where 
substantial between-study heterogeneity was evident (for participant characteristics and 
method of assessing development of upper limb spasticity), a narrative analysis of the data was 
performed.  
When there was low study heterogeneity, a meta-analysis comparing probabilities of incident 
spasticity occurring at one and six months post-baseline assessment for each of the variables 
was undertaken. Statistical heterogeneity was assessed by using the I2 and Chi2 tests. Where I2 
equated to 50% or more and Chi2 = p<0.10, a random-effects statistical model was used. When 
this was not the case, a fixed-effects statistical model was employed [20]. Data for categorical 
predictive markers were assessed to using odd ratios (OR) and 95% confidence intervals (CI) 












were conducted on Revman version 5.3 (The Cochrane Collaboration Statistical Software, 
Copenhagen, 2016). 
Results 
From the thorough search process, 11 papers were eligible for qualitative analysis. After 
discussion between all reviewers, one paper [21] was excluded due to not clearly exploring 
predictors of spasticity (Appendix Table B). Therefore 10 papers were included in the analyses 
(Figure 1).  
 
Insert Figure 1 about here 
 
Participant Characteristics 
A summary of the characteristics of the included papers is presented in Table 1. In total 856 
participants were included in the analysis; 518 (60.5%) were males and 338 (39.5%) were 
females. Side of stroke was reported in seven papers; 254 (48.9%) of participants having a left-
sided stroke and 265 (51.5%) had a right-sided stroke [21-26]. Six papers reported that 304 
(84.0%) had ischaemic stroke and 58 (16.0%) had haemorrhagic stroke [10,22-26,28]. From 
four studies, eight (2.5%) participants had cortical stroke, 12 (3.4%) had sub-cortical stroke 
and 19 (5.3%) had sub-cortical/cortical stroke [20]. The remaining studies presented the type 
of stroke according to the Oxford classification; 73 (20.5%) had a total anterior circulation 
stroke, 34 (9.6%) had a Lacunar stroke, 79 (22.2%) had a Partial anterior circulation stoke, 31 
(8.7%) had a Posterior circulation stroke [22,25], 85 (23.9%) had supratentorial stroke and 15 
(4.2%) had a infratentorial stroke [28].  
(Insert Table 1 about here) 












The Down’s and Black scores for each paper are presented in Table B. From the included 
studies, six presented with substantial quality (>65%) and four presented with low quality 
(<65%) (Appendix Table B) [18]. Strengths included that all: studies reported the aims of the 
study, provided estimates of the random variability in the data for the main outcomes, reported 
actual probability values and used appropriate statistical tests. Nine papers (90%) reported the 
accuracy of outcome measures chosen, description of the main findings and participants who 
were representative of the entire population from which they were recruited. Only two papers 
(20%) contained items about adjustment in the analysis [10,26]. One paper (10%) described 
the recruitment process and blinding [27] and another reported time to follow-up [10]. 
Meta-Analysis: Predictors of Upper Limb Spasticity 
Upper limb motor, somatosensory impairments and haemorrhagic stroke were statistical 
significant predictors of upper limb spasticity. Overall, there was a significant increase in the 
probability of spasticity at one-month and six-months post-stroke when measured by motor 
(OR:15.20, 95% confidence intervals (CI): 4.01 to 57.64; N=95; I2: 0%; p=0.54), 
somatosensory (OR: 3.56; 95% CI: 1.19 to 10.60, N=95; I2: 0%; p=0.46) upper limb 
impairments and haemorrhagic stroke (OR: 3.47; 95% CI: 1.22 to 9.89, N=116; I2: 0%; p=0.57) 
(Figures 2,3 and 4).  
(Insert Figures 2,3,4 about here) 
When analysed by period following baseline assessment (one month versus six months), at 
one-month post-stroke, all factors remained statistically significant (motor; OR: 11.25; 95% 
CI: 2.48 to 51.04, N=48, I2: 0%; p=0.55, somatosensory; OR: 4.91; 95% CI: 1.24 to 19.46; 
N=48; I2: 0%; p=0.46, haemorrhagic; OR: 3.70; 95% CI: 1.05 to 12.98; N=69; I2: 0%; p=0.57). 
Upper limb motor impairments were also significant predictors of spasticity at six months 












somatosensory upper limb impairments nor haemorrhagic stroke were not significant (OR: 
2.10; 95% CI: 0.35 to 12.76; N=47; I2: 0%; p=0.46, OR: 2.92; CI: 0.43 to 19.61; N=47; I2: 0%; 
p= 0.57 respectively) (Table 2). Age was also a significant predictor (OR: 0.01; 95% CI: 0.00, 
69.89; N=96; I2: 94%; p<0.0001). There was no statistically significant association between 
upper limb spasticity, ischemic stroke, side of stroke, level of smoking and gender (Table 2). 
 
(Insert Table 2 about here) 
Behavioural, biomechanical and neurophysiological predictors of upper limb spasticity  
Studies that explored the association between upper limb spasticity and behavioural measures 
showed that there was moderate quality evidence to indicate that severity of upper limb motor 
impairments when measured with instruments such as Birgitta Lindmark Motor Assessment, 
Upper Extremity Motricity Index and Fugl-Meyer Assessment were significant predictors of 
upper limb spasticity during the first six months post-stroke (r=0.51; p<.001) [28], (OR: 0.94; 
95% CI: 0.92-0.96; p<0.001) [24] and (OR 0.45; 95% CI:0.31-0.65,p=<0.001) [21]. As a result, 
people with moderate paresis (OR=0.23; 95% CI, 0.10 to 0.54; p=0.001) and mild paresis 
(OR=0.15; 95% CI, 0.07 to 0.35; p≤0.001) showed a decreased risk of developing spasticity 
compared with severe paresis [30]. Low scores of activities of daily living outcome measures 
such as Barthel Index or the modified version were also identified as predictors of upper limb 
spasticity at admission, at three (OR=1.03; 95% CI: 1.01-1.01, p=0.012) [24], (p<0.001) [29], 
four (p=0.002) [27] and six months post-stroke (p=<0.001) [29]. Finally, lower quality of life 
scores were associated with upper limb spasticity at six months post-stroke (p=0.001) [30].  
Two studies explored the association between biomechanical properties including contracture 
and stiffness and upper limb spasticity [26, 27]. Multiple linear regression that spasticity in 
addition with strength and contracture contributed to upper limb activity during the whole year 












measurement of motor impairments by Fugl Meyer Assessment (>18 score) at one month post-
stroke was a significant predictor of reflex stiffness gain measured by the elbow joint stretching 
motor device with force and position sensors (Coefficient: -4.42; p<0.001) [27]. 
One study reported the association between severe upper limb spasticity and brain lesion 
location in stroke patients using MRI derived voxel lesion mapping [23]. This reported that a 
significant greater number of MRI voxels relating to the stroke lesion were associated with 
upper limb spasticity (p=0.001) [23]. The main brain areas affected by upper limb spasticity 
from the first week to six months post-stroke were the basal ganglia, thalamus, anterior and 
posterior limbs of the retrolenticular part of the internal capsule, the anterior, superior, and 
posterior corona radiate, the external capsule and the superior longitudinal fasciculus.  
Discussion 
This systematic review identified that motor impairments and age was a significant predictor 
of upper limb spasticity during the first six months post-stroke. Somatosensory upper limb 
disturbance and haemorrhagic stroke also were also found as potential predictors at one month 
post-stroke; however not at six months. Narrative synthesis showed that severity of motor 
impairments, limitations in activities of daily living and low quality of life were also predictors 
of upper limb spasticity in the first six months post-stroke. 
The profile of the included participants in the review match the study population in that they 
had an equal amount of left and right sided strokes and cortical, sub-cortical and mixed strokes. 
Additionally, as expected, ischaemic stroke was more common [31] and the mean age of all 
the studies was above 60 years. The results of the meta-analysis indicated that age was a 
significant predictor of upper limb spasticity following stroke. The relationship between age 
and spasticity has never been specifically explored in stroke, but has been in paediatric 












severity, aetiology, performance of thrombolysis, gender, risk factors, and stroke 
complications. In light of the increase in ageing population could have an impact on higher 
incidence of upper limb spasticity [33]. This suggests that older adults, due to their increased 
risk of spasticity, may be less likely to achieve a good functional outcome than younger adults 
[34]. Haemorrhagic stroke presentations were also a significant predictor of upper limb 
spasticity, but only within the first month post-stroke. The relationship between haemorrhagic 
stroke and spasticity needs to be further using neurophysiological tools such as 
electroencephalography and functional Magnetic Resonance imaging through longitudinal 
studies involving people with stroke from the hyper acute to the chronic stage. 
Narrative analyses also showed that severity of upper limb motor impairments can predict 
upper limb spasticity and this was also reported in similar systematic reviews [13,14]. The 
meta-analyses results, also showed that level of motor and somatosensory upper limb 
impairments could predict spasticity. The association between motor impairments and 
spasticity comes as no surprise. However, when treating spasticity, it did not show any 
improvement in voluntary motor control [35]. Suggesting that hypertonia is more a cause of 
contracture than reflex hyperexcitability [36]. Upper limb somatosensory impairments have 
been reported as being ignored in stroke rehabilitation [37]. This review indicates sensory upper 
limb deficits may be predictor of upper limb spasticity, this is supported by a previous narrative 
review Sunnerhagen (2016). In the early stages post-stroke, patients with somatosensory upper 
limb impairments are more likely to have spasticity. Only one study explored and fully 
explained the clinical relationship between somatosensory upper limb impairments and 
spasticity and did not include a detailed somatosensory assessment [21]. Nearly 50% of stroke 
survivors with upper limb impairment experience somatosensory impairments such as 












post-stroke [38,39]. Future cross-sectional or longitudinal research in the acute and sub-acute 
stages could further explore this association.  
Future research undertaking greater biomechanical assessment to investigate the motor control 
reactions may help better understand the underlying neural mechanisms of spasticity [6]. In 
one of the included studies, measurements of contracture, reflex stiffness and weakness were 
identified as the major biomechanical contributors measured using electromyography to upper 
limb spasticity over 12 months post-stroke [24]. This a potential reason for botulinum toxin to 
be an effective treatment in reducing tone and managing spasticity post stroke [40,41]. Further 
research exploring both neurophysiological and biomechanical predictors of upper limb 
spasticity is warranted. More detailed knowledge about the affected cortical regions related to 
upper limb spasticity will provide a rationale for development of treatment modalities to target 
these neurophysiological areas.  
Whilst this review was conducted and reported in accordance with the PRISMA 
recommendations [42], it is not without limitations. Grey literature was not searched for this 
review which could have further strengthened the methodology. As four studies were reported 
as low quality, the results should be viewed with caution. The study population had a larger 
proportion of males than females which could have led to some gender bias. In particular, the 
papers poorly reported about the selection of the sample, length of follow-up and any 
adjustments in analysis. Due to the included papers reported prediction using inconsistent type 
of analyses, the narrative analysis presents the values as odds ratios, regression or coefficient 
data and even p values. Papers reported calculated prediction using different methods of 
analysis and therefore, The MAS is the most popular test to measure spasticity at the 
neurological hospital however, the outcome measure has limited reliability and poor validity 
[43]. The tool does not distinguish between neural and non-neural factors of spasticity. 












has fundamental limitations. Modified Tardieu Scale which measures resistance to movement 
at different velocities, seems more appropriate in evaluating spasticity [43]. Future research 
should therefore reconsider the use of this outcome measure in this population. 
Conclusions 
Upper limb spasticity is common post-stroke. This review identified age as a significant 
predictor. Motor, somatosensory deficits and haemorrhagic stroke were also identified as 
predictors for upper limb spasticity within the first month post-stroke. Narrative analysis 
showed that severity of motor impairments, limitations in activities of daily living and low 
quality of life were also predictors of upper limb spasticity in the first six months post-stroke. 
Future research should further explore the biomechanical and neurophysiological predictors of 
upper limb spasticity. By identifying such predictors this will then allow physiotherapists to 
select patients with stroke who are at high risk and choose treatment accordingly.  
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 Motor impairments, sensory deficits, haemorrhagic stroke and stroke were identified 
as a significant predictors of upper limb spasticity 
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Figure 1: PRISMA Flow Diagram showing process of the selection of studies 
 













Figure 3: Forest plot displaying the odds ratio analysis for upper limb somatosensory impairments and spasticity 
 


























Table 1: Summary of selected papers 
Selected Paper 
Aim of paper 
Sample Size 
included in 





baseline assessments  
Time-points for follow-





Opheim et al. 
2015 
To identify predictor variables 
and the optimal time for early 
prediction of any spasticity and 
sever severe spasticity in the 
upper limb 1 year post-stroke 
117 Mean (SD) age: 67.2 (12.0) 
years 
Gender: 60M, 40F 
Type of stroke: 82I; 18H 





At admission to stroke 
unit and at 3 days  









- Side of paresis 
- Stroke location 
 
At 3 days: 
- Upper limb motor 
impairments 
- Upper limb 
sensation 
Picelli et al. 2014a  To determine the association 
between stroke lesion location 
and severe upper limb post-
stroke spasticity using brain 
voxel-based lesion symptom 
mapping procedures 
39 Mean (SD) age: 72.7 (7.19) 
years 
Gender: 24M, 15F 
Type of stroke: 39I 
Mean (SD) ESS: 74.4 (20.5) 





Picelli et al. 2014b  To investigate the prognostic 
value of topical distribution of 
initial paresis of the upper limb 
for predicting clinically relevant 
spasticity in patients with 
ischemic stroke 
72 Mean (SD) age: 70.6 (10.4) 
years 
Gender: 48M, 24F 
Type of stroke: 72I 
 
<7 days - 6 months  Clinical: 
Motor items of 
ESS*  
 
Kong et al. 2012  To conduct a prospective study 
to document the temporal 
development and evolution of 
upper limb spasticity and 
163 
 
Mean (SD) age: 63.8 (10.7) 
years 
Gender: 111M, 52F 
Type of stroke: 163I 
Admission to 
rehabilitation  
- 6 months 
















establish clinical correlates and 
predictors of upper limb 
spasticity in a cohort of stroke 
patients admitted to an inpatient 
rehabilitation unit 
Mean (SD)UEMI: 35.8(30.8) - Severity of stroke 
- Sensation  
- Upper extremity 
motor strength 
Mirabegheri et al. 
2011 
To quantify the changes in 
neural and muscular properties 
associated with spasticity in the 
upper extremity of stroke 
survivors at different time-
intervals over 1-year post-stroke 
21 Mean (SD) age: 64 (12) years 
Gender: 11M, 10F 
Type of stroke: 6I; 15H 
Mean (SD) FMA at 1 month: 
25 (23) 
1 month - 2 months 
- 3 months 
- 6 months 
- 12 months 
Clinical:  







controlled motor to 
drive elbow position 





Lundstorm et al. 
2010 
To explore the occurrence of and 
risk factors for spasticity until 
first 6 months after stroke 
49 Median (min-max) age: 74 
(35-84) years 
Gender: 28M; 21F 
Type of stroke: 41I; 8H 
 
2-10days - 1 month 




- Stroke type 
(Ischemic/Hemorrh
agic) 
- Stroke severity 
- Disability 
- Sensory 
distribution of pain 
Urban et al. 2010 To investigate the prevalence of 
spasticity after motor stroke and 
to identify clinical predictors of 
subsequent spasticity 
301 Mean (SD) age: 68(13) years 
Gender: 131M; 80F 
Type of stroke: 301I 
Mean (SD) NIHSS score: 6.6 
(4.6) 
<5 days - 6 months  Clinical:  
- Age 
- Gender 












Wissel et al. 2010 To follow a cohort of patients 
from immediate days after stroke 
to assess frequency and 
development of spasticity and 
identifies risk-factors for 
development of post-stroke 
spasticity 
94 Mean age: 69 years 
Gender: 38% Female 
Type of stroke: 86%I; 14%H 
 
<12 days - 6 weeks 




- Type of stroke 
(Ischemic/Hemorrh
agic) 
- Lesion site 
- Lesion side 
Ada et al. 2006 To determine the relative 
contribution of weakness to the 
secondary impairment 
contracture of spasticity 
27 Mean (SD) age: 63(11) years 
Gender: 20M; 7F 
 
2 weeks  4 weeks 
 6 weeks 
 9 weeks 
 17 weeks 
 26 weeks 
 39 weeks 





EMG* amplifier to 
measure strength 
and contracture at 
elbow 
 
Sommerfeld et al.  
2004  
To describe the extent spasticity 
occurs and is associated with 
disabilities initially and 3 months 
after stroke 
95 Mean (SD) age: 78(9.5) years 
Gender: 35M; 60F 
Mean 5.4 days - 3 months Clinical:  
- Upper limb Motor 
impairments 
* BI=Barthel Index; BL= Birgitta Lindmark Motor Assessment; EMG=Electromyography; ESS= European Stroke Scale; F= Female; FMA=Fugl Meyer Assessment; H= Haemorrhagic; I= Ischaemic; M=Male; 
MAS=Modified Ashworth Scale; MBI=Modified Barthel Index; MRI=Magnetic Resonance Imaging; MoAS=Motor Assessment Scale; MRS=Modified Rankin Scale; NIHSS=National Institutes of Health Stroke Scale; 




















OR (95% CI) I2/Chi2 
Age Cumulative 96 0.01 (0.00, 69.86) 94% / 
P<0.0001 
Gender (male) Cumulative 227 (4) 1.73 (0.96, 3.12) 24% / P=0.26 
 1 108 (3) 1.99 (0.86, 4.47) 24% / P=0.26 
 6 119 (2) 1.47 (0.62, 3.49) 24% / P=0.26 
Gender (female) Cumulative 227 (4) 0.73 (0.40, 1.32) 0% / P=0.87 
 1 108 (3) 0.77 (0.34, 1.76) 0% / P=0.87 
 6 119 (2) 0.68 (0.29, 1.61) 0% / P=0.87 




6 72 (1) 1.67 (0.41, 6.80) Not 
estimatable 
Handedness (Left) 6 72 (1) 0.60 (0.15, 2.45) Not 
estimatable 
Upper limb motor 
impairments 
Cumulative 95 (1) 15.20 (4.01, 57.64)* 0% / P=0.54 
1 48 11.25 (2.48, 51.04)* 0% / P=0.55 




Cumulative 95 (1) 3.56 (1.19, 10.60)* 0% / P=0.46 
 1 48 (1) 4.91 (1.24, 19.46)* 0% / P=0.46 
6 47 (1) 2.10 (0.35, 12.76) 0% / P=0.46 
Side of Stroke 
(Left) 
Cumulative 132 (3) 0.84 (0.42, 1.67) 0% / P=0.49 
1 60 (2) 1.24 (0.44, 3.52) 0% / P=0.49 
6 72 (1) 0.60 (0.23, 1.55) 0% / P=0.49 
Side of Stroke 
(Right) 
Cumulative 132 (3) 1.20 (0.60, 2.40) 0% / P=0.49 
1 60 (2) 0.80 (0.28, 2.27) 0% / P=0.49 
6 72 (1) 1.67 (0.65, 4.30) 0% / P=0.49 
Location of stroke 
(Subcortical) 
1 39 (1) 0.35 (0.08, 1.57) Not 
estimatable 
Location of stroke 
(Cortical) 
1 39 (1) 1.25 (0.24, 6.57) Not 
estimatable 
Location of stroke 
(Mixed) 
1 39 (1) 2.10 (0.56, 7.81) Not 
estimatable 
Type of Stroke 
(Ischaemic) 
Cumulative 116 (2) 0.29 (0.10, 0.82) 0% / P=0.57 
1 69 (2) 0.27 (0.08, 0.95) 0% / P=0.57 
6 47 (1) 0.34 (0.05, 2.31) 0% / P=0.57 
Type of Stroke 
(Haemorrhagic) 
Cumulative 116 (2) 3.47 (1.22, 9.89)* 0% / P=0.57 
1 69 (2) 3.70 (1.05, 12.98)* 0% / P=0.57 
6 47 (1) 2.92 (0.43, 19.61) 0% / P=0.57 
*=significant 
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